Wagner, Gernot
Steiner, Daniel
Ohrenberger, Gerald
Smeikal, Michael
Gisinger, Christoph
Moertl, Deddo
Nopp, Stephan
Gartlehner, Gerald
Pabinger, Ingrid
Ay, Cihan
Article History
Received: 15 April 2024
Accepted: 11 July 2024
First Online: 31 July 2024
Competing interests
: GW, DS, CG, DM, SN, GG, and GO have no conflicts of interest. MS received honoraria from Eli Lilly, Novartis, Pfizer, Amgen, Sanofi-Aventis, Roche, and Boehringer. IP received honoraria for lectures and participation in advisory boards from Bayer, and BMS/Pfizer, none had a role in the design of the study. CA received honoraria for lectures and participation in advisory boards from Bayer, BMS/Pfizer, Daiichi-Sankyo and Sanofi. Pfizer Austria had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript; or in the decision to publish the results.